{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"24.000","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"118,995,206","primaryexch":"香港交易所","ric":"6127.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0988,"inline_upper_strike_price":"","sedol":"BNK9Q76","am":"113.74","iv":"","ew_strike":"","as":"23.100","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"23.000","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-28 00:06:03.0","lo52":"6.990","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"馮宇霞","underlying_ric":"603127.SS","hi52":"28.700","issuer_name":"北京昭衍新藥研究中心股份有限公司 - H股","h_share_flag":true,"ew_sub_per_from":"","div_yield":"0.14","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"23.000","mkt_cap":"2.74","f_aum_hkd":null,"ew_sub_per_to":"","ls":"23.100","nav_date":"","csic_classification":"醫藥衛生","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-1.140","aum":"","issued_shares_class_B":null,"vo":"4.85","secondary_listing_flag":false,"listing_date":"2021年2月26日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"北京昭衍新藥研究中心股份有限公司 - H股","nm_s":"昭衍新藥","sym":"6127","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"北京昭衍新藥研究中心股份有限公司是一家主要從事新藥藥理毒理學研究的中國公司。該公司透過三個分部開展業務。藥物非臨床研究服務分部主要提供藥品非臨床安全性評估服務、藥效學研究服務、藥物動力學研究服務。臨床服務及其他分部主要提供藥品上市前的臨床服務及藥物警戒服務。實驗模型供應分部為實驗模型及其附屬產品的生產與銷售。該公司主要在中國國內和海外市場開展業務。","op":"24.000","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國北京<br/>北京經濟技術開發區<br/>榮京東街甲5號<br/>郵編：100176","pc":"-4.70","days_to_expiry":null,"underlying_code":null,"pe":"221.05","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"24.240","isin":"CNE100004BP3","moneyness":""}},"qid":"1759074140070"}
